Pharmafile Logo

Glaucoma in perspective

- PMLiVE

2015 set to be a transitional year for Merck KGaA’s health unit

Weak pharma sales reported by the firm today

- PMLiVE

Endo buys Par for $8bn as M&A mania marches on

Acquisitionwill make Endo the fifth largest generics company in the US

- PMLiVE

Genzyme and Ablynx collaborate on multiple sclerosis research

Companies will investigate Nanobodies against MS target

- PMLiVE

GSK unveils board and committee changes

Manvinder Singh Banga named as a non-executive director

- PMLiVE

Delivering accessible healthcare

The future of consumer health, community pharmacists and collaboration

Getting real about patient support

The right application of data can have a transformative effect on patient care

- PMLiVE

Get Real! The Rise of Observational Data In Healthcare

Real world data is now becoming a serious research tool for pharma, but just what can it add to the golden standard that is the randomised clinical trial?

- PMLiVE

Pfizer launches lupus study with 23andMe

Aims to enroll 5,000 patients into new geneticresearch study

- PMLiVE

Can Advertising adds new lead designer

CorinneJones brings experience from DDB Remedy and Havas Life Medicom

UK flag

London life science growth boosted by Takeda

Japanese firm adds to recent surge in pharma spending in the capital

- PMLiVE

FDA warns of safety concern with SGLT2 inhibitors

Some drugs have been linked to high levels of blood acids

- PMLiVE

Allergy specialist Circassia buys asthma firms

British-based company acquires Sweden’s Aerocrine and privately held Prosonix

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links